emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Esteve Pharmaceuticals / HRA Pharma Rare Diseases

No EMAT : 117378
Announced Date : 25/04/2024
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Esteve Pharmaceuticals

Target : HRA Pharma Rare Diseases
Country : Hauts-De-Seine
Sector of activity :
  • Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
HRA Pharma Rare Diseases is specialized in rare and ultra- rare diseases. > HRA Pharma Rare Diseases has a portfolio of medicines (Metopirone, Lysodren, and Ketoconazole HRA) that address Cushing’s...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
05/06/2024 Rohto Pharmaceuticals Co MoNo chem-pharm Produkte (Sigmapharm) Austria * 117090
27/03/2024 Private group led by Carvest, Siparex Capron Podologie Saône-Et-Loire * 116883

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report